Aclaris Therapeutics (ACRS)
(Delayed Data from NSDQ)
$1.22 USD
-0.02 (-1.61%)
Updated Aug 6, 2024 04:00 PM ET
After-Market: $1.28 +0.06 (4.92%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth F Momentum F VGM
Earnings News For ACRS
-
Aclaris Therapeutics (ACRS) Reports Q1 Loss, Tops Revenue Estimates
-
Aclaris: Q1 Earnings Snapshot
-
Aclaris Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update
-
Aclaris: Q4 Earnings Snapshot
-
Aclaris Therapeutics (ACRS) Reports Q4 Loss, Tops Revenue Estimates
-
Aclaris Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update
-
Will Aclaris Therapeutics (ACRS) Report Negative Q4 Earnings? What You Should Know
-
Aclaris: Q3 Earnings Snapshot
-
Aclaris Therapeutics Reports Third Quarter 2023 Financial Results and Provides a Corporate Update
-
Aclaris Therapeutics (ACRS) Reports Q2 Loss, Tops Revenue Estimates
-
Aclaris Therapeutics Reports Second Quarter 2023 Financial Results and Provides a Corporate Update
-
Aclaris Therapeutics (ACRS) Reports Q1 Loss, Tops Revenue Estimates
-
Aclaris: Q1 Earnings Snapshot
-
Aclaris Therapeutics Reports First Quarter 2023 Financial Results and Provides a Corporate Update
-
Aclaris Therapeutics (ACRS) Reports Q4 Loss, Tops Revenue Estimates
-
Aclaris: Q4 Earnings Snapshot
-
Aclaris Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides a Corporate Update
-
Aclaris Therapeutics (ACRS) Reports Q3 Loss, Tops Revenue Estimates
-
Aclaris: Q3 Earnings Snapshot
-
Aclaris Therapeutics Reports Third Quarter 2022 Financial Results and Provides a Corporate Update
-
Aclaris Therapeutics (ACRS) Reports Q2 Loss, Misses Revenue Estimates
-
Aclaris Therapeutics Reports Second Quarter 2022 Financial Results and Provides a Corporate Update
-
Aclaris Therapeutics (ACRS) Reports Q1 Loss, Misses Revenue Estimates
-
Aclaris Therapeutics (ACRS) Reports Q4 Loss, Misses Revenue Estimates
-
Earnings Preview: Aclaris Therapeutics (ACRS) Q4 Earnings Expected to Decline